Resource Hub

Molecular HPV Testing: 6.6% Revenue Growth 2023-2028

January is Cervical Health Awareness Month, a reminder that more than 95% of cervical cancer cases are attributed to the human papillomavirus (HPV), according to the World Health Organization (WHO). HPV testing is a key…

January 2, 2024

|Daniel Granderson

NGS in Molecular Diagnostics

The first NGS system was approved for clinical use by the FDA only in 2013. Hence, the market segment is quite new, even though a significant industry exists for LDTs performed as testing services on…

January 11, 2023

|Bruce Carlson